These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16078986)

  • 41. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA; Katsafouros K; Möller HJ; Medori R; Sacchetti E
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute dystonic reaction to lithium and risperidone.
    Durrenberger S; de Leon J
    J Neuropsychiatry Clin Neurosci; 1999; 11(4):518-9. PubMed ID: 10570771
    [No Abstract]   [Full Text] [Related]  

  • 43. What happened to patients with behavioural and psychological symptoms of dementia (BPSD) after the Committee on Safety in Medicines (CSM) guidelines?
    Raju J; Sikdar S; Krishna T
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):898-9. PubMed ID: 16116573
    [No Abstract]   [Full Text] [Related]  

  • 44. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Risperidone and cerebrovascular accidents].
    Moreno Alvarez PJ; Madurga Sanz M
    Farm Hosp; 2003; 27(3):201-2. PubMed ID: 12835825
    [No Abstract]   [Full Text] [Related]  

  • 46. Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2007 Aug; 22(6):361-4. PubMed ID: 17562519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
    Lim HK; Pae CU; Lee C; Lee CU
    Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD; Saleem PT; Glue P; Arnoldussen WJ; Teijeiro R; Lex A; Latif MA; Medori R
    Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone-induced sexual dysfunction in a prepubertal child - a case report.
    Wadoo O; Chalhoub N
    J Psychopharmacol; 2009 Aug; 23(6):727-8. PubMed ID: 18562402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risperidone-induced erythema multiforme minor.
    Desarkar P; Nizamie SH
    Br J Clin Pharmacol; 2006 Oct; 62(4):504-5. PubMed ID: 16822277
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.
    Melkersson KI
    Hum Psychopharmacol; 2006 Dec; 21(8):529-32. PubMed ID: 17094165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSM warning on atypical psychotics and stroke may be detrimental for dementia.
    Mowat D; Fowlie D; MacEwan T
    BMJ; 2004 May; 328(7450):1262. PubMed ID: 15155521
    [No Abstract]   [Full Text] [Related]  

  • 55. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dementia induced by antipsychotic drugs].
    Watanabe H; Tominaga K; Ogino A; Sekino K; Aoba A
    Nihon Rinsho; 2004 Jan; 62 Suppl():466-9. PubMed ID: 15011407
    [No Abstract]   [Full Text] [Related]  

  • 57. Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review.
    Mazzucco S; Cipriani A; Barbui C; Monaco S
    Mini Rev Med Chem; 2008 Jul; 8(8):776-83. PubMed ID: 18673133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antipsychotics for treatment of neuropsychiatric disorders in dementia].
    Gertz HJ; Stoppe G; Müller-Oerlinghausen B; Schmidt LG; Baethge C; Hiemke C; Lieb K; Bschor T
    Nervenarzt; 2013 Mar; 84(3):370-3. PubMed ID: 23242013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Is risperidone responsible for respiratory manifestations?].
    Touraine F; Clavel M; Gericot-Pean E; Antonini MT; Nouaille Y; Ratti A; Lombertie ER; Bonnaud F
    Rev Mal Respir; 2000 Feb; 17(1):117-8. PubMed ID: 10756565
    [No Abstract]   [Full Text] [Related]  

  • 60. Risperidone induced cytopenias.
    Biswas A; Mittal P; Chaturvedi S; Prasad A
    J Assoc Physicians India; 2000 Nov; 48(11):1122-3. PubMed ID: 11310398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.